Status:
COMPLETED
Human Partial Facial Allotransplantation
Lead Sponsor:
Xijing Hospital
Conditions:
Pharmaceutical Preparations
Eligibility:
MALE
18-40 years
Phase:
PHASE3
Brief Summary
Progress in composite tissue allotransplantation provides a new remedy for severely disfigured patients. We plan to carry out allograft composite tissue transplantation after a careful systemic prepar...
Detailed Description
Severe facial deformities caused by burn, trauma, or tumor resection, are usually organs defects, such as ear, nose, eyelid, or lips and tissue defects involving the skin, fat tissue, muscle, cartilag...
Eligibility Criteria
Inclusion
- normal function of heart/liver/kidney
- donor: same boold type
- at least 3 sites were matched within 6 HLA sites
Exclusion
- abnormal function of heart/liver/kidney
- donor: not the same boold type and 1 or 2 sites were matched within 6 HLA sites
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00663988
Start Date
April 1 2006
Last Update
April 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032